1. Home
  2. Material Detail: CRISPRed Macrophages for Cell-Based Cancer Immunotherapy

Material Detail

CRISPRed Macrophages for Cell-Based Cancer Immunotherapy

CRISPRed Macrophages for Cell-Based Cancer Immunotherapy

We present here an integrated nanotechnology/biology strategy for cancer immunotherapy that uses arginine nanoparticles (ArgNPs) to deliver CRISPR-Cas9 gene editing machinery into cells to generate SIRP-α knockout macrophages. 

Disciplines:
Go to Material 
Bookmark / Add to Course ePortfolio
Create a Learning Exercise
Add Accessibility Information
Rate
Add a Comment

Quality

  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Material Type:
Reference Material
Date Added to MERLOT:
August 5, 2021
Date Modified in MERLOT:
August 5, 2021
Author:
Unknown (Know the author?)
Submitter:
Mary Bemker
Primary Audience:
College Upper Division, Graduate School, Professional
Technical Format:
Website
Mobile Compatibility:
Not specified at this time
Technical Requirements:
Accessed viaa Google Chrome.
Language:
English
Cost Involved:
No
Source Code Available:
Yes
Creative Commons:
Unknown

Browse...

Disciplines with similar materials as CRISPRed Macrophages for Cell-Based Cancer Immunotherapy
People who viewed this also viewed
Other materials like CRISPRed Macrophages for Cell-Based Cancer Immunotherapy

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.